Opinion/decision on a Paediatric investigation plan (PIP): Leqvio,Inclisiran sodium, decision type: , therapeutic area: , PIP number: P/0495/2022

Opinion/decision on a Paediatric investigation plan (PIP): Leqvio,Inclisiran sodium, decision type: , therapeutic area: , PIP number: P/0495/2022

Opinion/decision on a Paediatric investigation plan (PIP): Sarclisa,Isatuximab, decision type: , therapeutic area: , PIP number: P/0494/2022

Opinion/decision on a Paediatric investigation plan (PIP): Sarclisa,Isatuximab, decision type: , therapeutic area: , PIP number: P/0494/2022

Opinion/decision on a Paediatric investigation plan (PIP): Imvanex,Modified Vaccinia Ankara - Bavarian Nordic virus (smallpox), decision type: , therapeutic area: , PIP number: P/0539/2022

Opinion/decision on a Paediatric investigation plan (PIP): Imvanex,Modified Vaccinia Ankara - Bavarian Nordic virus (smallpox), decision type: , therapeutic area: , PIP number: P/0539/2022

Overview of comments received on 'Guideline on quality, safety and efficacy of veterinary medicinal products specifically designed for phage therapy'

Overview of comments received on 'Guideline on quality, safety and efficacy of veterinary medicinal products specifically designed for phage therapy'

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.